RAMELLA, SARA
 Distribuzione geografica
Continente #
AS - Asia 9.451
NA - Nord America 1.114
EU - Europa 1.092
SA - Sud America 22
AF - Africa 19
OC - Oceania 15
Totale 11.713
Nazione #
SG - Singapore 8.170
US - Stati Uniti d'America 1.059
CN - Cina 661
HK - Hong Kong 506
IT - Italia 430
GB - Regno Unito 197
DE - Germania 162
NL - Olanda 82
EE - Estonia 57
FI - Finlandia 48
IN - India 47
CA - Canada 41
BR - Brasile 18
TR - Turchia 18
UA - Ucraina 16
ZA - Sudafrica 16
CZ - Repubblica Ceca 14
SE - Svezia 14
MX - Messico 13
AU - Australia 12
FR - Francia 11
ID - Indonesia 11
ES - Italia 10
PL - Polonia 10
JP - Giappone 9
AT - Austria 8
RO - Romania 8
BD - Bangladesh 7
CH - Svizzera 5
LT - Lituania 4
TW - Taiwan 4
TH - Thailandia 3
BE - Belgio 2
BG - Bulgaria 2
CL - Cile 2
IL - Israele 2
IR - Iran 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
DK - Danimarca 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
HU - Ungheria 1
IE - Irlanda 1
IQ - Iraq 1
JM - Giamaica 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
OM - Oman 1
PH - Filippine 1
PK - Pakistan 1
RS - Serbia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SL - Sierra Leone 1
VN - Vietnam 1
Totale 11.713
Città #
Hong Kong 440
Hefei 396
Singapore 394
Ashburn 263
Boardman 195
London 170
Shanghai 137
Rome 133
Munich 103
Beijing 84
Council Bluffs 60
Los Angeles 57
Amsterdam 38
San Francisco 36
Turku 28
Pune 26
Washington 26
Seattle 25
Milan 21
Toronto 21
Helsinki 20
Chicago 19
Naples 19
Santa Clara 17
Brooklyn 15
Dallas 14
Boston 12
Brno 12
New York 12
Sona 11
Stockholm 10
São Paulo 10
West Jordan 10
Atlanta 9
Mexico City 9
Warsaw 9
Bologna 8
Charlotte 8
Florence 7
Nuremberg 7
Palermo 7
Phoenix 7
Tokyo 7
Ankara 6
Hanover 6
Montreal 6
Redmond 6
Buffalo 5
Chennai 5
Johannesburg 5
Melbourne 5
Rocca di Papa 5
Vicenza 5
Cascina 4
Denver 4
Frankfurt am Main 4
Haikou 4
Providence 4
Umeå 4
Andover 3
Aprilia 3
Bangkok 3
Canberra 3
Castelfranco Veneto 3
Central 3
Charleston 3
Gravina di Catania 3
Guangzhou 3
Handan 3
Lucca 3
Markham 3
New Delhi 3
Sydney 3
Turin 3
Vaddangi 3
Vienna 3
Azzano San Paolo 2
Bangalore 2
Banqiao 2
Bari 2
Birmingham 2
Bratislava 2
Brent 2
Bucharest 2
Calgary 2
Cleveland 2
Clifton 2
Cologno Monzese 2
Concord 2
Dhaka 2
East Orange 2
Genoa 2
Hangzhou 2
Harbin 2
Jakarta 2
Lima 2
Livorno 2
Manchester 2
Marseille 2
Mumbai 2
Totale 3.089
Nome #
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 233
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 231
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 224
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy: systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium 217
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial 202
Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung) 201
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 200
RadioPathomics: Multimodal Learning in Non-Small Cell Lung Cancer for Adaptive Radiotherapy 194
Ten years experience with breast reconstruction after salvage mastectomy in previously irradiated patients: analysis of outcomes, satisfaction and well-being 194
Repeated courses of radiation treatment in an HER2-positive breast cancer patient with diffuse brain metastases: A case report 193
Exploring Deep Pathomics in Lung Cancer 193
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 190
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 188
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 187
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 187
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 187
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 185
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 184
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 183
Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports 181
Radiotherapy for pain relief from bone metastases during Coronavirus (COVID-19) pandemic 181
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 179
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 179
A morphing technique to estimate lung cancer deformation due to breathing in radiotherapic treatment 178
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 177
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 176
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 171
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 170
Preventing Cardiotoxicity in Personalized Breast Irradiation 169
Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging 167
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort 165
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 128
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 119
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 106
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 103
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 102
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 100
A cast of shadow on adjuvant radiotherapy for prostate cancer: A critical review based on a methodological perspective. 100
Laparoscopic total mesorectal excision (L-TME) for rectal cancer surgery: Does elective diverting ileostomy really protect? An observational retrospective cohort study 98
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 98
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 94
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 94
MR imaging of rectal cancer before and after chemoradiation therapy 94
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 93
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 93
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 93
Deep Reinforcement Learning for Fractionated Radiotherapy in Non-Small Cell Lung Carcinoma 92
Evaluating GANs in Medical Imaging 92
How I Treat Localized Soft Tissue Sarcomas: Update on Diagnosis, Risk Stratification, and Treatment 90
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 90
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 90
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 89
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 88
A deep learning approach for overall survival prediction in lung cancer with missing values 88
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 87
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 87
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 87
Application of a practical method for the isocenter point in vivo dosimetry by a transit signal 85
Novel Skin Toxicity of Epidermal Growth Factor Receptor Inhibitors: A Case of Intertrigo-Like Eruption in a Patient with Metastatic Colorectal Cancer Treated with Cetuximab 84
Can we prevent COVID-19 from causing victims among uninfected cancer patients? 84
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 83
Chemoradiation for stage III non-small cell lung cancer 81
Design and evaluation of a methodology to perform personalized visual biofeedback for reducing respiratory amplitude in radiation treatment 80
Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer 79
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 78
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 71
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 68
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 67
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 66
Are We Ready for Histology-Driven Stereotactic Ablative Radiotherapy? 65
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 64
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 64
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 58
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 41
Protective Role of Natural Compounds under Radiation-Induced Injury 35
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 31
Radiation therapy of breast cancer. Reasoned approach to a clinical case 31
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 30
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 29
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 27
Expression of the RNA-binding protein HuR and its clinical significance in human stage I and II lung adenocarcinoma. 27
Radiation Therapy in management of malignant pleural mesothelioma: Pros (2). 27
ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer. 26
Radioprotezione 26
Dose fractionation and biological optimization in lung cancer 25
Neoadjuvant concurrent chemotherapy and radiotherapy in non-small cell lung cancer 24
Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine 24
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 24
Breakthrough pain management in patients undergoing radiotherapy: a national survey on behalf of the Palliative and Supportive Care Study Group. 23
The role of postoperative thoracic radiotherapy and prophylactic cranial irradiation in early stage small cell lung cancer: Patient selection among ESTRO experts. 23
Ruolo della Radioterapia. In: “Percorso Terapeutico nel Carcinoma Polmonare (NSCLC)” 23
PATTERN OF FAILURE AFTER ADAPTIVE RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC). 23
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement 23
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 22
Lung Cancer in Italy. 22
Proton beam or photon beam radiotherapy in the treatment of non-small-cell lung cancer 22
Initial experience of ArcCHECK and 3DVH software for RapidArc treatment plan verification 22
Il trattamento radioterapico del Mesotelioma Pleurico 22
Evidence-Based Radiotherapy: “Hot Topics” 2010 NSCLC 22
PO-0672 Ten years experience of breast reconstruction after mastectomy in previously irradiated patients 22
Totale 10.234
Categoria #
all - tutte 68.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 6 6 5 1 3 6 6 13 7 0 168
2022/2023172 1 1 2 8 8 1 24 6 74 0 38 9
2023/2024592 21 62 36 35 60 251 14 36 4 22 11 40
2024/20259.995 96 48 221 64 113 219 153 34 522 725 3.591 4.209
2025/2026842 614 228 0 0 0 0 0 0 0 0 0 0
Totale 11.822